Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 258
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Virulence ; 14(1): 2218077, 2023 12.
Artículo en Inglés | MEDLINE | ID: mdl-37248708

RESUMEN

Neutrophil dysregulation is well established in COVID-19. However, factors contributing to neutrophil activation in COVID-19 are not clear. We assessed if N-formyl methionine (fMet) contributes to neutrophil activation in COVID-19. Elevated levels of calprotectin, neutrophil extracellular traps (NETs) and fMet were observed in COVID-19 patients (n = 68), particularly in critically ill patients, as compared to HC (n = 19, p < 0.0001). Of note, the levels of NETs were higher in ICU patients with COVID-19 than in ICU patients without COVID-19 (p < 0.05), suggesting a prominent contribution of NETs in COVID-19. Additionally, plasma from COVID-19 patients with mild and moderate/severe symptoms induced in vitro neutrophil activation through fMet/FPR1 (formyl peptide receptor-1) dependent mechanisms (p < 0.0001). fMet levels correlated with calprotectin levels validating fMet-mediated neutrophil activation in COVID-19 patients (r = 0.60, p = 0.0007). Our data indicate that fMet is an important factor contributing to neutrophil activation in COVID-19 disease and may represent a potential target for therapeutic intervention.


Asunto(s)
COVID-19 , Metionina , Humanos , Activación Neutrófila , Péptidos , N-Formilmetionina/farmacología , Racemetionina , Neutrófilos , Complejo de Antígeno L1 de Leucocito
2.
J Exp Ther Oncol ; 11(2): 125-132, 2017 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-28976135

RESUMEN

OBJECTIVE: Chemopreventive agents which exhibit activities such as anti-inflammation, inhibition of carcinogen induced mutagenesis and scavenging of free radical might play a decisive role in the inhibition of chemical carcinogenesis either at the initiation or promotion stage. Many synthesized palladium (Pd) complexes tested experimentally for antitumor activity are found effective. Poly-MVA is a liquid blend preparation containing B complex vitamins, ruthenium with Pd complexed with alpha lipoic acid as the major ingredients. The antitumor effect of Poly-MVA was evaluated against 7,12-dimethylbenz[a] anthracene-initiated croton oil-promoted papilloma formation on mice skin. Skin tumor was initiated with a single application of 390 nmol of DMBA in 20 µl acetone. The effect of Poly-MVA against croton oil- induced inflammation and lipid peroxidation on the mice skin was also evaluated. Topical application of Poly-MVA (100 µl, twice weekly for 18 weeks) 30 minutes prior to each croton oil application, significantly decreased the tumor incidence (11%) and the average number of tumor per animals. Application of Poly-MVA (100 µl) before croton oil significantly (p &#60; 0.05) protected the mouse skin from inflammation (36%) and lipid peroxidation (14%) when compared to the croton oil alone treated group. Experimental results indicate that Poly-MVA attenuate the tumor promoting effects of croton oil and the effect may probably be due to its anti-inflammatory and antioxidant activity.


Asunto(s)
Suplementos Dietéticos , Depuradores de Radicales Libres/farmacología , Peroxidación de Lípido/efectos de los fármacos , Paladio/farmacología , Papiloma/patología , Neoplasias Cutáneas/patología , Ácido Tióctico/farmacología , Complejo Vitamínico B/farmacología , 9,10-Dimetil-1,2-benzantraceno/toxicidad , Acetilcisteína/farmacología , Animales , Carcinógenos/toxicidad , Aceite de Crotón/toxicidad , Femenino , Inflamación , Ratones , Molibdeno/farmacología , N-Formilmetionina/farmacología , Papiloma/inducido químicamente , Papiloma/metabolismo , Rodio/farmacología , Rutenio/farmacología , Neoplasias Cutáneas/inducido químicamente , Neoplasias Cutáneas/metabolismo
3.
Arch Microbiol ; 180(2): 88-100, 2003 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-12819857

RESUMEN

An ABC-type transporter in Escherichia coli that transports both L- and D-methionine, but not other natural amino acids, was identified. This system is the first functionally characterized member of a novel family of bacterial permeases within the ABC superfamily. This family was designated the methionine uptake transporter (MUT) family (TC #3.A.1.23). The proteins that comprise the transporters of this family were analyzed phylogenetically, revealing the probable existence of several sequence-divergent primordial paralogues, no more than two of which have been transmitted to any currently sequenced organism. In addition, MetJ, the pleiotropic methionine repressor protein, was shown to negatively control expression of the operon encoding the ABC-type methionine uptake system. The identification of MetJ binding sites (in gram-negative bacteria) or S-boxes (in gram-positive bacteria) in the promoter regions of several MUT transporter-encoding operons suggests that many MUT family members transport organic sulfur compounds.


Asunto(s)
Transportadoras de Casetes de Unión a ATP/genética , Transportadoras de Casetes de Unión a ATP/metabolismo , Proteínas de Escherichia coli , Escherichia coli/metabolismo , Metionina/metabolismo , N-Formilmetionina/farmacología , Proteínas Bacterianas/fisiología , Evolución Biológica , Transporte Biológico Activo , Escherichia coli/genética , Escherichia coli/crecimiento & desarrollo , Regulación Bacteriana de la Expresión Génica , Metionina/farmacología , Operón , Filogenia , Proteínas Represoras/fisiología
4.
J Biol Chem ; 275(3): 1781-6, 2000 Jan 21.
Artículo en Inglés | MEDLINE | ID: mdl-10636875

RESUMEN

Structurally different fluorescent probes were covalently attached to methionyl-tRNA(f) and tested for their incorporation into nascent peptides and full-length protein using an Escherichia coli cell-free coupled transcription/translation system. Bovine rhodanese and bacterial chloramphenicol acetyltransferase (CAT) were synthesized using derivatives of cascade yellow, eosin, pyrene, or coumarin attached to [(35)S]Met-tRNA(f). All of the probes tested were incorporated into polypeptides, although less efficiently when compared with formyl-methionine. Eosin, the largest of the fluorophores used with estimated dimensions of 20 x 11 A, caused the largest reduction in product formed. The rate of initiation was reduced with the fluorophore-Met-tRNA(f) compared with fMet-tRNA(f) with pyrene having the least and eosin the biggest effect. Analysis of the nascent polypeptides showed that the modifications at the N terminus affected the rate at which nascent CAT peptides were elongated causing accumulation of peptides of about 4 kDa, possibly by steric hindrance inside the tunnel within the 50 S ribosomal subunit. Fluorescence measurements indicate that the probe at the N terminus of nascent pyrene-CAT peptides is in a relatively hydrophilic environment. This finding is in agreement with recent data showing cross-linking of the N terminus of nascent peptides to nucleotides of the 23 S ribosomal RNA.


Asunto(s)
Cloranfenicol O-Acetiltransferasa/metabolismo , Colorantes Fluorescentes/farmacología , Biosíntesis de Proteínas/efectos de los fármacos , Ribosomas/enzimología , Animales , Bovinos , Cloranfenicol O-Acetiltransferasa/genética , Cumarinas/farmacología , Eosina Amarillenta-(YS)/farmacología , Cinética , N-Formilmetionina/farmacología , Biosíntesis de Péptidos , Péptidos/química , Péptidos/metabolismo , Pliegue de Proteína , Pirenos/farmacología , ARN de Transferencia de Metionina/metabolismo , Espectrometría de Fluorescencia , Tiosulfato Azufretransferasa/farmacología , Factores de Tiempo
5.
Arthritis Rheum ; 34(10): 1289-96, 1991 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-1718285

RESUMEN

We evaluated basophil releasability in 16 female patients with scleroderma (systemic sclerosis) and in 16 normal age- and sex-matched donors. Basophils from patients with scleroderma released significantly more histamine "spontaneously" than did those from normal donors (12.9 +/- 2.1% versus 4.5 +/- 0.7%; P less than 0.0005). Basophil reactivity (maximal percentage histamine release) to anti-IgE was higher in patients with scleroderma than in controls (57.0 +/- 7.5% versus 35.4 +/- 7.8%; P less than 0.05). Basophil sensitivity (the concentration of anti-IgE that causes 40% of maximal percentage histamine release) to anti-IgE in scleroderma patients was similar to that found in controls (4.6 +/- 2.8 x 10(-2) micrograms/ml versus 2.3 +/- 1.0 x 10(-1) micrograms/ml; P not significant). Scleroderma patients also showed enhanced releasability compared with that of the controls when challenged in vitro with interleukin-3 (8.3 +/- 1.7% versus 3.2 +/- 0.6%; P less than 0.01). Releasability induced by the formyl-containing tripeptide, f-met peptide, was significantly higher in the scleroderma patients than in the controls at the 2 lower concentrations used. No differences in basophil reactivity and sensitivity to f-met peptide and calcium ionophore A23187 were found between patients and normal donors. These results show that spontaneous basophil releasability and releasability in response to IgE cross-linking and activation of interleukin-3 receptors are increased in patients with scleroderma.


Asunto(s)
Basófilos/inmunología , Esclerodermia Sistémica/inmunología , Adulto , Anciano , Basófilos/efectos de los fármacos , Basófilos/metabolismo , Calcimicina/farmacología , Relación Dosis-Respuesta a Droga , Femenino , Liberación de Histamina/inmunología , Humanos , Inmunoglobulina E/sangre , Interleucina-3/farmacología , Persona de Mediana Edad , N-Formilmetionina/farmacología , Proteínas Recombinantes
6.
Biochem J ; 257(1): 51-6, 1989 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-2920026

RESUMEN

A formylmethionine deformylase from rat small-intestinal mucosa has been isolated, characterized and partially purified. The enzyme catalyses the release of equimolar amounts of formate and the free amino acid. The deformylase was active against formylmethionine (Km 7.1 mM) and formylnorleucine, but showed reduced activity against formyl-leucine. It was inactive against a range of other polar and nonpolar formyl-amino acids and against formyl di- and tri-peptides. The Mr of the native enzyme was between 45,000 and 66,000, as determined by h.p.l.c. gel permeation. Further purification of the enzyme either by h.p.l.c. ion-exchange chromatography and concanavalin A-Sepharose or by isoelectric focusing yielded a preparation with one predominant band of Mr 50,000 on SDS/polyacrylamide-gel electrophoresis. Bacteria in the intestine present the host with substantial amounts of formylmethionine (fMet) from proteinase and carboxypeptidase digestion of bacterial formyl-peptides in the intestinal lumen. fMet (0.01-1.0 mM) inhibited translation of a test RNA from brome mosaic virus in vitro, indicating that it could have adverse effects on cellular metabolism. Gut epithelial fMet deformylase may be required for deformylation of this exogenous (bacterial) and also endogenous (mitochondrial) fMet.


Asunto(s)
Amidohidrolasas/aislamiento & purificación , Intestino Delgado/enzimología , Animales , Mucosa Intestinal/enzimología , Masculino , Peso Molecular , N-Formilmetionina/metabolismo , N-Formilmetionina/farmacología , Biosíntesis de Proteínas/efectos de los fármacos , ARN Viral/metabolismo , Ratas , Ratas Endogámicas
7.
J Immunol ; 139(9): 3062-9, 1987 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-2444649

RESUMEN

Our previous studies of human lung and intestinal mast cells failed to show the heterogeneity found among mast cells in murine species. Recently, we and others have developed techniques for the enzymatic dispersion of human neonatal skin mast cells. In addition, we are now able to make single cell suspensions of mast cells from adult skin and to purify these cells to near homogeneity. Comparative studies of mast cells from these several sources have uncovered several major differences among them. Adult and neonatal skin mast cells themselves differ in that the former are 10-fold less sensitive to goat anti-human IgE, with maximal release occurring at 3.0 and 0.3 microgram/ml, respectively. Skin mast cells also differ in optimal temperature for release: adult mast cells respond maximally at 23 to 30 degrees C and neonatal cells at 37 degrees C. Skin mast cells from both sources are dramatically different from lung and intestinal mast cells in two aspects. First, skin mast cells are quite responsive to several stimuli--morphine sulfate (10(-4) to 10(-6) M), substance P (10(-5) to 10(-7) M), compound 48/80 (10 to 0.1 microgram/ml), f-Met peptide (10(-6) M), and C5a (10(-8) M)--to which the other mast cells fail to respond. Second, although stimulated skin mast cells produce prostaglandin D2, little leikotriene C4, if any, is generated, unlike lung or intestinal mast cells. These differences in inflammatory potential among human mast cells from various sites have important implications for the management of allergic and inflammatory responses.


Asunto(s)
Mastocitos/citología , Piel/citología , Calcio/fisiología , Separación Celular , Complemento C5/farmacología , Complemento C5a , Liberación de Histamina , Humanos , Inmunoglobulina E/fisiología , Recién Nacido , Pulmón/citología , Mastocitos/fisiología , N-Formilmetionina/farmacología , Prostaglandina D2 , Prostaglandinas D/biosíntesis , SRS-A/biosíntesis , Sustancia P/fisiología
8.
Immunology ; 50(1): 35-41, 1983 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-6193056

RESUMEN

The functionally predominant constituents of the slow-reacting substance of anaphylaxis (SRS-A), designated leukotrienes C4 and D4 (LTC4 and LTD4), as well as the leucocyte chemotactic factor leukotriene B4 (LTB4) enhance the adherence of human neutrophils to Sephadex G-25. Enhancement of neutrophil adherence was significant at leukotriene concentrations of 3 X 10(-9) M -3 X 10(-7) M, and reached a maximum level for each of the leukotrienes that was similar in magnitude to that evoked by the neutrophil chemotactic peptide N-formyl-methionyl-leucylphenylalanine (FMLP). The leukotrienes and FMLP elicited optimum increases in neutrophil adherence within 1-2 min at 37 degrees. Indomethacin inhibited the increase in neutrophil adherence evoked by LTC4 and LTD4 and the concurrent elevation in the concentration of endogenous thromboxane B2. The smooth muscle contractile and vasoactive factors LTC4 and LTD4, which lack chemotactic activity for leucocytes, are as active as LTB4 in stimulating human neutrophil adherence, and the effect may be mediated in part by neutrophil-derived thromboxane A2.


Asunto(s)
Leucotrieno B4/farmacología , Neutrófilos/efectos de los fármacos , SRS-A/farmacología , Ácidos Araquidónicos/metabolismo , Adhesión Celular/efectos de los fármacos , Células Cultivadas , Dextranos , Relación Dosis-Respuesta a Droga , Geles , Humanos , Indometacina/farmacología , N-Formilmetionina/análogos & derivados , N-Formilmetionina/farmacología , N-Formilmetionina Leucil-Fenilalanina , Neutrófilos/metabolismo , Oligopéptidos/farmacología , Tromboxano B2/metabolismo , Factores de Tiempo
9.
Immunology ; 50(1): 65-73, 1983 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-6309653

RESUMEN

The release of leukotriene B4 (LTB4) from human neutrophils and its relationship to degranulation induced by the divalent cation ionophore A23187, serum-treated zymosan (STZ), N-formyl-methionyl-leucyl-phenylalanine (FMLP) and arachidonic acid (AA) have been studied. Greatest release of LTB4, measured by specific radioimmunoassay, occurred in response to A23187 (5-10 ng/10(6) cells); lower concentrations were obtained after incubation with STZ (0.2-0.8 ng/10(6) cells) and AA (0.3-2.6 ng/10(6) cells) and low (0.02 ng/10(6) cells) or not detectable amounts from cells incubated with FMLP. Release of LTB4 induced by STZ, FMLP and submaximal concentrations of A23187 was potentiated by simultaneous addition of AA. Lower amounts (0.06-0.3 ng/10(6) cells) of thromboxane B2 (TXB2) were also released by these stimuli, however this release of TXB2 was not potentiated by exogenous AA. The secretion of beta-glucuronidase induced by A23187, STZ and FMLP was not quantitatively related to release of LTB4 or TXB2 and was not potentiated by exogenous AA. Furthermore, FMLP induced degranulation was cytochalasin B (Cyt B)-dependent, whereas LTB4 release in response to this stimulus was only marginally increased by pretreatment of the cells with Cyt B. These data indicate that LTB4 does not mediate degranulation induced by these stimuli.


Asunto(s)
Antibacterianos/farmacología , Calcimicina/farmacología , Leucotrieno B4/biosíntesis , Metionina/análogos & derivados , N-Formilmetionina/análogos & derivados , Neutrófilos/metabolismo , Oligopéptidos/farmacología , Zimosan/farmacología , Ácidos Araquidónicos/farmacología , Células Cultivadas , Gránulos Citoplasmáticos/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Glucuronidasa/biosíntesis , Humanos , N-Formilmetionina/farmacología , N-Formilmetionina Leucil-Fenilalanina , Neutrófilos/efectos de los fármacos , Tromboxano B2/biosíntesis
10.
J Invest Dermatol ; 81(3): 254-7, 1983 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-6309987

RESUMEN

Psoriatic patients, particularly those with psoriatic arthritis, have neutrophilic and eosinophilic leukocytosis. Isolated polymorphonuclear leukocytes (PMNLs) from psoriatic patients have normal concentrations of proteolytic enzymes and they have beta-adrenergic receptors of normal density and affinity. PMNLs from psoriatic patients responded normally to the synthetic chemotactic peptide, f-Met-Leu-Phe (formyl-methionine-leucine-phenylalanine). The chemotactic activities of sera from psoriatic patients were similar to those of normal sera. Sera from psoriatic patients enhanced chemokinesis of PMNLs more than normal control sera at a final concentration of 1%; no difference in chemokinetic response between psoriatic and normal sera was found at serum concentrations greater than 2.5%. This study suggests that the peripheral PMNLs from psoriatic patients are normal, but the sera of psoriatic patients has more chemokinetic activity for PMNLs than does normal serum.


Asunto(s)
Quimiotaxis de Leucocito , Neutrófilos/fisiología , Péptido Hidrolasas/sangre , Psoriasis/fisiopatología , Receptores Adrenérgicos beta/metabolismo , Receptores Adrenérgicos/metabolismo , Humanos , N-Formilmetionina/análogos & derivados , N-Formilmetionina/farmacología , N-Formilmetionina Leucil-Fenilalanina , Neutrófilos/enzimología , Oligopéptidos/farmacología
11.
Science ; 221(4618): 1413-5, 1983 Sep 30.
Artículo en Inglés | MEDLINE | ID: mdl-6310757

RESUMEN

The concentration of cytosolic ionized calcium, [Ca2+]i, was measured in intact neutrophils by use of a fluorescent indicator trapped in the icytoplasm. A given rise of [Ca2+]i elicited by the chemotactic peptide formylmethionylleucylphenylalanine (FMLP) was associated with a much greater degree of superoxide generation and myeloperoxidase secretion than was the same or larger [Ca2+]i produced by a specific calcium ionophore, ionomycin, which bypasses cell surface receptors. Thus, FMLP appears to generate some important excitatory signal in addition to a rise in [Ca2+]i and exocytosis and superoxide generation in neutrophils may not be simply dependent on [Ca2+]i as is widely supposed.


Asunto(s)
Calcio/fisiología , Exocitosis , Neutrófilos/fisiología , Oxígeno/metabolismo , Superóxidos/metabolismo , Citoplasma/fisiología , Éteres/farmacología , Humanos , Ionomicina , Ionóforos/farmacología , Lisosomas/enzimología , N-Formilmetionina/análogos & derivados , N-Formilmetionina/farmacología , N-Formilmetionina Leucil-Fenilalanina , Oligopéptidos/farmacología
12.
FEBS Lett ; 161(1): 60-4, 1983 Sep 05.
Artículo en Inglés | MEDLINE | ID: mdl-6884528

RESUMEN

The respiratory burst of polymorphonuclear leukocytes, induced by the addition of chemotactic peptide (N-formyl-methionyl-leucyl-phenylalanine) and cytochalasin B was found to consist of two phases. The first phase of very rapid oxygen uptake lasted 1-3 min. and was followed by a second more prolonged phase of lower magnitude. The apparent Km for oxygen of unstimulated cells was 9.6 +/- 0.67 microM, while that of the second phase of stimulation was 3.7 +/- 1.6 microM oxygen. The possibility that lowered oxygen concentrations may regulate polymorphonuclear leukocyte activity in some pathological conditions is discussed.


Asunto(s)
Neutrófilos/metabolismo , Consumo de Oxígeno , Oxígeno/sangre , Animales , Quimiotaxis de Leucocito/efectos de los fármacos , Citocalasina B/farmacología , Cinética , N-Formilmetionina/análogos & derivados , N-Formilmetionina/farmacología , N-Formilmetionina Leucil-Fenilalanina , Neutrófilos/efectos de los fármacos , Oligopéptidos/farmacología , Consumo de Oxígeno/efectos de los fármacos , Ratas
13.
Am J Physiol ; 245(3): C196-202, 1983 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-6412560

RESUMEN

The ability of the chemotactic peptide N-formylmethionyl-leucyl-phenylalanine (FMLP) to stimulate beta-glucuronidase release and 45Ca2+ release from rabbit neutrophils was studied. FMLP stimulated enzyme release from cytochalasin B-treated cells either in the presence or the absence of extracellular calcium. Depletion of cell calcium, by exposure to either ethyleneglycol-bis(beta-aminoethylether)-N,N'-tetraacetic acid or the calcium ionophore A23187, blocked the ability of FMLP to stimulate enzyme release and 45Ca2+ release in the absence of extracellular calcium. The ability of A23187 to lower the 45Ca2+ content of neutrophils, to block FMLP-stimulated 45Ca2+ release, and to inhibit FMLP-stimulated enzyme release in the absence of calcium was dose dependent over the same concentration range (10(-8) to 10(-6) M A23187) for all three actions. In contrast, FMLP stimulated enzyme release from A23187-treated cells, provided that extracellular calcium was present. This secretory response was normal as judged by cell ultrastructure and FMLP dose-response relationships. It is concluded that A23187 depletes a pool of intracellular calcium usually released by FMLP and that release of calcium from this pool is necessary for initiation of enzyme secretion in the absence of extracellular calcium.


Asunto(s)
Calcio/sangre , Quimiotaxis de Leucocito/efectos de los fármacos , Metionina/análogos & derivados , N-Formilmetionina/análogos & derivados , Neutrófilos/enzimología , Oligopéptidos/farmacología , Animales , Calcimicina/farmacología , Ácido Egtácico/farmacología , Femenino , Glucuronidasa/sangre , Glucuronidasa/metabolismo , Cinética , Lisosomas/efectos de los fármacos , Lisosomas/enzimología , Masculino , Microscopía Electrónica , N-Formilmetionina/farmacología , N-Formilmetionina Leucil-Fenilalanina , Neutrófilos/efectos de los fármacos , Neutrófilos/ultraestructura , Conejos
15.
Blood ; 62(2): 274-9, 1983 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-6307427

RESUMEN

Cetiedil citrate monohydrate inhibits sickling of red cells and aggregation of platelets. We assessed its ability to attenuate polymorphonuclear leukocyte (PMN) function. PMN aggregation in response to 2 X 10(-7) M formyl-met-leu-phe (FMLP) was inhibited in a dose-dependent fashion by cetiedil concentrations ranging from 60 to 250 microM. Additionally, 125 microM cetiedil inhibited PMN aggregation in response to 2 X 10(-7) M FMLP, 20 ng/ml phorbol myristate acetate (PMA), and 1 X 10(-6) M A23187 by 69% +/- 18%, 72% +/- 20%, and 65% +/- 4%, respectively. Inhibition of FMLP-induced aggregation was provided by only 5 min of incubation of the drug with the cells and was partially reversible. Cell viability was unaffected by exposure of PMN to the drug. Correspondingly, 125 microM cetiedil prevented the translocation of calcium from the PMN membrane as assessed by chlorotetracycline fluorescence. Paralleling the effect of the drug on PMN aggregation, 125 microM cetiedil inhibited release of superoxide by 55% and decreased the number of available 3H-FMLP receptors. However, its effect on release of the primary granule constituent, myeloperoxidase, was minimal (4.5% inhibition), while the effect on release of the specific granule product, lactoferrin (27% inhibition), was modest. These studies indicate that cetiedil affects PMN aggregation and superoxide release to a much greater extent than PMN degranulation. Thus, cetiedil may have potential uses in modulating inflammatory response in vivo.


Asunto(s)
Azepinas/farmacología , Neutrófilos/efectos de los fármacos , Sitios de Unión/efectos de los fármacos , Calcio/metabolismo , Agregación Celular/efectos de los fármacos , Citocalasinas/farmacología , Humanos , Lactoferrina/sangre , N-Formilmetionina/análogos & derivados , N-Formilmetionina/metabolismo , N-Formilmetionina/farmacología , N-Formilmetionina Leucil-Fenilalanina , Oligopéptidos/metabolismo , Oligopéptidos/farmacología , Peroxidasa/sangre , Superóxidos/metabolismo
16.
J Infect Dis ; 148(2): 194-9, 1983 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-6310000

RESUMEN

Pregnancy has been associated with alterations of polymorphonuclear neutrophil (PMN) function. Superoxide anion production was studied in pregnant women paired with nonpregnant women of childbearing age. There was a significant decrease in the amount of cytochrome c reduced in response to 1 microM N-formylmethionylleucylphenylalanine (fMet-Leu-Phe) but not to phorbol myristate acetate, 4 or 20 ng/ml. Chemotaxis was also depressed. Binding of tritiated fMet-Leu-Phe to PMNs from pregnant women was not defective. Incubation of normal cells in up to 10(-6) M estradiol or progesterone did not mimic the defect, but 10(-7) M progesterone caused a decrease in chemotaxis. Serum pooled from women with the defect had no effect on superoxide anion production by normal PMNs. PMN rosetting with IgG-sensitized human erythrocytes was normal. Defective production of superoxide anion may contribute to the amelioration of connective tissue disease and increased susceptibility to infection often seen during pregnancy.


Asunto(s)
Metionina/análogos & derivados , N-Formilmetionina/análogos & derivados , Neutrófilos/metabolismo , Oligopéptidos/farmacología , Oxígeno/metabolismo , Superóxidos/metabolismo , Quimiotaxis de Leucocito/efectos de los fármacos , Estradiol/farmacología , Femenino , Humanos , N-Formilmetionina/metabolismo , N-Formilmetionina/farmacología , N-Formilmetionina Leucil-Fenilalanina , Neutrófilos/efectos de los fármacos , Neutrófilos/inmunología , Oligopéptidos/metabolismo , Embarazo , Progesterona/farmacología , Receptores Fc , Acetato de Tetradecanoilforbol/farmacología
17.
Proc Natl Acad Sci U S A ; 80(14): 4349-53, 1983 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-6308617

RESUMEN

Chemoattractant N-formylmethionylleucylphenylalanine (fMet-Leu-Phe) in the presence of cytochalasin B stimulates the release of leukotriene B4 (LTB4), superoxide (O2-), and N-acetylglucosaminidase from elicited rat peritoneal and human peripheral neutrophils [PMN (polymorphonuclear leukocytes)]. Prostaglandins E1 and E2 (PGE1 and PGE2) inhibit LTB4 release from PMN in a dose-related manner with an IC50 of 1 X 10(-8) M. This action is associated with increased levels of cyclic AMP. The inhibitory activity of a variety of PGs on LTB4 production by rat peritoneal PMN parallels their affinity for PGE receptors in other tissues. O2- release is also suppressed by low levels of PGE1 and PGE2 in a dose-related manner and this inhibition is enhanced by theophylline. In contrast, lysosomal enzyme release is only minimally affected by physiological levels of PGs. These data are consistent with an action of PGs at the level of the PG receptor on LTB4 and O2- release from the fMet-Leu-Phe-stimulated rat peritoneal PMN. In addition, the fMet-Leu-Phe-induced adherence of PMN to endothelial cells and inhibition of this phenomenon by PGs may now be explained by PG-mediated inhibition of LTB4 formation.


Asunto(s)
Leucotrieno B4/sangre , Neutrófilos/metabolismo , Prostaglandinas E/farmacología , Alprostadil , Quimiotaxis de Leucocito/efectos de los fármacos , Dinoprostona , Humanos , Cinética , Leucotrieno B4/metabolismo , N-Formilmetionina/análogos & derivados , N-Formilmetionina/farmacología , N-Formilmetionina Leucil-Fenilalanina , Neutrófilos/efectos de los fármacos , Oligopéptidos/farmacología , Teofilina/farmacología
18.
Biochim Biophys Acta ; 758(2): 168-75, 1983 Jul 29.
Artículo en Inglés | MEDLINE | ID: mdl-6307386

RESUMEN

The results presented in this paper demonstrate that the chemotactic peptide N-formylmethionylleucylphenylalanine (f-Met-Leu-Phe) is rapidly inactivated by the products of the respiration of human neutrophils stimulated by the peptide itself. The process of inactivation is impeded by the addition of inhibitors of myeloperoxidase (KCN, NaN3), of catalase, of methionine but not by the addition of superoxide dismutase, indicating that the mechanism of inactivation is the oxidation of methionine residue by myeloperoxidase-H2O2-halide system. The oxidation of the peptide causes the rapid cessation of the respiratory burst, since the sulfoxide derivative loses its ability to bind the specific receptors of neutrophil surface and, hence, its biological activity. The comparison between the time course of the binding of f-Met-Leu-[3H]Phe to the specific receptors and the rate of the respiratory response of neutrophils in the presence and in the absence of the process of peptide oxidation was used to investigate the mechanism of the activation of the respiratory burst by the peptide-receptor complexes. In conditions where the inactivation of the stimulatory agent takes place the stimulated respiration slows down and resumes the resting state shortly after the cessation of the binding, although a substantial amount of the peptide remains bound to the specific receptors. In conditions where the degradation of the peptide does not occur the binding of the peptide and the respiratory burst continue for a longer period of time, but the rate of the respiration, calculated in terms of the instantaneous velocity (Vist), is not correlated to the amount of the ligand bound to the membrane receptors measured at various times, indicating that a summation of the effects of the ligand-receptor complexes does not occur as they form. These findings demonstrate, as far as the respiratory response is concerned, that the biological activity of the peptide-receptor complexes is short-lived and that continuous de-novo receptor occupancy is necessary for the maintenance of the activated respiration.


Asunto(s)
Metionina/análogos & derivados , N-Formilmetionina/análogos & derivados , Neutrófilos/metabolismo , Oligopéptidos/metabolismo , Consumo de Oxígeno , Factores Quimiotácticos/metabolismo , Humanos , Cinética , N-Formilmetionina/metabolismo , N-Formilmetionina/farmacología , N-Formilmetionina Leucil-Fenilalanina , Neutrófilos/efectos de los fármacos , Oligopéptidos/farmacología , Consumo de Oxígeno/efectos de los fármacos , Cianuro de Potasio/farmacología , Superóxidos/metabolismo
19.
J Clin Invest ; 72(1): 113-21, 1983 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-6308042

RESUMEN

The complement-derived anaphylatoxin C5a and a putative analogue of bacterial chemotactic factor (N-formyl-methionyl-leucyl-phenylalanyl [fMLP]), as well as bacterial lipid A, all stimulate human granulocyte (PMN) adhesiveness and superoxide (O-2) production in a concentration-dependent manner. Since attachment of particulate matter to the PMN membrane is an early event in the triggering of respiratory burst of these cells, we further examined how adherence might modulate the release of O-2 induced by soluble mediators of inflammation. We found that both the quantity and kinetics of O-2 production depend on prior attachment of the cells to a surface. In stirred suspensions of PMN, fMLP induces only a short burst (2.5 min) of O-2 release associated with reversible PMN aggregation. The magnitude, but not the time course, of both these responses depend on the fMLP concentration. Unlike the short respiratory response of cells in suspension, PMN allowed to settle onto stationary petri dishes, then overlaid with fMLP, rapidly spread and attach to the surface where they remain and release O-2 throughout the 60-min test period. Prolonged O-2 release also follows fMLP stimulation in suspensions of PMN pretreated with cytochalasin B, in which case aggregation becomes irreversible during the 20-min burst. If fMLP is slowly infused into a suspension of cells at 37 degrees C or if PMN are challenged at 0 degrees C, and then warmed to 37 degrees C, O-2 release greatly decreases or becomes undetectable. Suspended PMN do not respond to a second challenge by the same stimulus regardless of the rate or temperature at which the first stimulus was added, a phenomenon formerly described as desensitization. However, if PMN challenged with fMLP in suspension undergo the short respiratory response and then are later placed in petri dishes, they adhere and resume production of O-2 without further stimulation. Chemotactic factor-induced adherence and O-2 release of PMN on a surface is entirely independent of either the mode of activation or prior O-2 release during preincubation in suspension. Human C5a also promotes PMN adherence and prolonged O-2 release in petri dishes. Furthermore, lipid A increases O-2 release and adherence of settled PMN, but fails to elicit either response from suspended PMN. These results indicate that cell surface contact plays an essential role in triggering the respiratory burst of PMN activated by soluble stimuli. This long-lasting O-2 release by chemotactic factor-stimulated PMN may play a significant role in inflammatory reactions when PMN become adherent in vivo.


Asunto(s)
Comunicación Celular , Neutrófilos/metabolismo , Oxígeno/metabolismo , Superóxidos/metabolismo , Adulto , Adhesión Celular/efectos de los fármacos , Comunicación Celular/efectos de los fármacos , Factores Quimiotácticos/farmacología , Complemento C5/fisiología , Complemento C5a , Citocalasina B/farmacología , Humanos , Cinética , Lípido A/farmacología , N-Formilmetionina/análogos & derivados , N-Formilmetionina/farmacología , N-Formilmetionina Leucil-Fenilalanina , Oligopéptidos/farmacología
20.
Immunobiology ; 165(1): 97-106, 1983 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-6885104

RESUMEN

The local amine anesthetic tetracaine added to a suspension of guinea pig or human neutrophilic granulocytes inhibited their random migration in Boyden chambers, but increased their chemotactic migration towards the chemotactic tripeptide f-Met-Leu-Phe, complement-activated normal guinea pig serum, and the eosinophil chemotactic factor ECF. Tetracaine not only increased the distance migrated by the leading cells, it also caused more cells to leave the upper filter surface and to migrate into the filter. The effect required the presence of the drug; cells preincubated with tetracaine and washed did not differ from control cells. It is suggested that tetracaine specifically enhanced a mechanism operative in a cell's response to a concentration gradient of a chemotactic factor.


Asunto(s)
Quimiotaxis de Leucocito/efectos de los fármacos , Tetracaína/farmacología , Animales , Fenómenos Fisiológicos Sanguíneos , Tampones (Química) , Movimiento Celular/efectos de los fármacos , Factores Quimiotácticos Eosinófilos/fisiología , Cobayas , Humanos , N-Formilmetionina/análogos & derivados , N-Formilmetionina/farmacología , N-Formilmetionina Leucil-Fenilalanina , Neutrófilos , Oligopéptidos/farmacología , Albúmina Sérica Bovina/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA